AGORACOM Small Cap 60: Valeo Pharma Asthma Drug In Partnership With Novartis Exceeds Company Expectations

A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Reply New Message

Prev Message Back To Forum Threaded View Next Message

agoracom administrator

Rank: Administrator [?]

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

AGORACOM Small Cap 60: Valeo Pharma Asthma Drug In Partnership With Novartis Exceeds Company Expectations

posted on Sep 30, 2021 11:22AM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply